Navigation Links
Novel Technique For Identification And Treatment Of Neurodegenerative Diseases

A new technique has been developed to identify and localize the presence of tiny iron oxide particles associated with neurodegenerative disorders, more specifically Alzheimer's. // The finding could eventually pave way for the development of a first real time diagnostic procedure for Alzheimer's.

The identification is based on equipment called synchrotron, (a device that accelerates electrons to produce high intensity X-rays). The equipment has numerous applications in the physics related experiments. The researchers from University of Florida incorporated lenses and mirrors to the usual set up to enable analysis of brain tissue. The depth of examination and precision are main advantages of this device.

The electron microscope can provide adequate resolution of 1 micron (1/1000th of a centimeter). The new device can allow identification and subsequent examination of particles as small as 200-300 microns in size. 'It's the equivalent of being up in an airplane, looking at the city of Tampa, and telling you whether there is a penny there or not. And then once we zoom in, we can tell you what kind of penny it is,' remarked Dr. Davidson, one of the senior researchers.

Diseases such as Alzheimer's, Parkinson's and Huntington's affect millions worldwide and pose a significant strain on the financial resources. The number is only expected to increase in the forthcoming years. All these diseases share some common features such as dementia and physical impairment. It is also known that specific brain regions afflicted with the above-mentioned disorders are likely to contain elevated levels of iron oxide and other iron particles.

Currently, the role of iron in neurodegenerative disorders is poorly understood. It is known that iron is essential for normal functioning of the brain. Consistent with the above fact, small amounts of iron is present in healthy brains as well.

It is unclear if iron causes such disorders or iron depos ition is a characteristic symptom of the same. The new technique could accelerate research on the cause of such neurodegenerative disorders.

Conventional methods used for identification of such iron particles rely on staining of tissue sections. The disadvantage of these methods is that it does not highlight the presence of specific compounds of iron. In addition, it is also not possible to relate iron compounds to specific regions of the brain.

An improved understanding of the disease process could lead to effective treatment strategies in the years to come. The researchers further intend to explore if magnetic resonance imaging (MRI) can be used to highlight 'iron induced brain damage' in affected patients.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: